✦ LIBER ✦

TIMI Risk Index and the Benefit of Enoxaparin in Patients with ST-Elevation Myocardial Infarction

✍ Scribed by Christian T. Ruff; Stephen D. Wiviott; David A. Morrow; Satishkumar Mohanavelu; Sabina A. Murphy; Elliott M. Antman; Eugene Braunwald

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thrombolysis in Myocardial Infarction (T

✍ Quynh A. Truong; Christopher P. Cannon; Neil A. Zakai; Ian S. Rogers; Robert P. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 406 KB

Performance of the Thrombolysis in Myoca

✍ Saif S. Rathore; Kevin P. Weinfurt; JoAnne M. Foody; Harlan M. Krumholz 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 309 KB

Effect of enoxaparin versus unfractionat

✍ David A. Morrow; Elliott M. Antman; Sabina A. Murphy; Jie Qin; Mikhail Ruda; Sem 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 379 KB

Enoxaparin as adjunctive antithrombin th

✍ E.M. Antman; H.W. Louwerenburg; H.F. Baars 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Validation of the Thrombolysis In Myocar

✍ Benjamin M Scirica; Christopher P Cannon; Elliott M Antman; Sabina A Murphy; Dav 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Sequential risk stratification using TIM

✍ Dimitrios Karmpaliotis; Minang P. Turakhia; Ajay J. Kirtane; Sabina A. Murphy; I 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB